Report Detail
Global (United States, European Union and China) Drugs for Oral Mucositis Market Research Report 2019-2025
- RnM3664211 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the sales of Mouthwash are 16.9 million units, with its market share 48.8%. And the sales market share of Pain Control Medication is 38% in 2017.
Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 69.6% in 2017.
In 2019, the market size of Drugs for Oral Mucositis is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drugs for Oral Mucositis.
This report studies the global market size of Drugs for Oral Mucositis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drugs for Oral Mucositis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Biovitrum
Valeant Pharmaceuticals
EUSA Pharma
Camurus
Mission Pharmacal
Clinigen Group
Midatech Pharma
Alliance Pharma
AMAG Pharmaceuticals
Market Segment by Product Type
Mouthwash
Pain Control Medication
Other
Market Segment by Application
Hospitals
Dental Clinics
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drugs for Oral Mucositis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drugs for Oral Mucositis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drugs for Oral Mucositis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Drugs for Oral Mucositis Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Mouthwash
- 1.3.3 Pain Control Medication
- 1.3.4 Other
- 1.4 Market Segment by Application
- 1.4.1 Global Drugs for Oral Mucositis Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Dental Clinics
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Drugs for Oral Mucositis Market Size
- 2.1.1 Global Drugs for Oral Mucositis Revenue 2014-2025
- 2.1.2 Global Drugs for Oral Mucositis Sales 2014-2025
- 2.2 Drugs for Oral Mucositis Growth Rate by Regions
- 2.2.1 Global Drugs for Oral Mucositis Sales by Regions 2014-2019
- 2.2.2 Global Drugs for Oral Mucositis Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Drugs for Oral Mucositis Sales by Manufacturers
- 3.1.1 Drugs for Oral Mucositis Sales by Manufacturers 2014-2019
- 3.1.2 Drugs for Oral Mucositis Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Drugs for Oral Mucositis Revenue by Manufacturers (2014-2019)
- 3.2.2 Drugs for Oral Mucositis Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Drugs for Oral Mucositis Market Concentration Ratio (CR5 and HHI)
- 3.3 Drugs for Oral Mucositis Price by Manufacturers
- 3.4 Key Manufacturers Drugs for Oral Mucositis Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Drugs for Oral Mucositis Market
- 3.6 Key Manufacturers Drugs for Oral Mucositis Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Mouthwash Sales and Revenue (2014-2019)
- 4.1.2 Pain Control Medication Sales and Revenue (2014-2019)
- 4.1.3 Other Sales and Revenue (2014-2019)
- 4.2 Global Drugs for Oral Mucositis Sales Market Share by Type
- 4.3 Global Drugs for Oral Mucositis Revenue Market Share by Type
- 4.4 Drugs for Oral Mucositis Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Drugs for Oral Mucositis Sales by Application
6 United States
- 6.1 United States Drugs for Oral Mucositis Breakdown Data by Company
- 6.2 United States Drugs for Oral Mucositis Breakdown Data by Type
- 6.3 United States Drugs for Oral Mucositis Breakdown Data by Application
7 European Union
- 7.1 European Union Drugs for Oral Mucositis Breakdown Data by Company
- 7.2 European Union Drugs for Oral Mucositis Breakdown Data by Type
- 7.3 European Union Drugs for Oral Mucositis Breakdown Data by Application
8 China
- 8.1 China Drugs for Oral Mucositis Breakdown Data by Company
- 8.2 China Drugs for Oral Mucositis Breakdown Data by Type
- 8.3 China Drugs for Oral Mucositis Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Drugs for Oral Mucositis Breakdown Data by Company
- 9.2 Rest of World Drugs for Oral Mucositis Breakdown Data by Type
- 9.3 Rest of World Drugs for Oral Mucositis Breakdown Data by Application
- 9.4 Rest of World Drugs for Oral Mucositis Breakdown Data by Countries
- 9.4.1 Rest of World Drugs for Oral Mucositis Sales by Countries
- 9.4.2 Rest of World Drugs for Oral Mucositis Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 3M Healthcare
- 10.1.1 3M Healthcare Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.1.4 Drugs for Oral Mucositis Product Introduction
- 10.1.5 3M Healthcare Recent Development
- 10.2 GSK
- 10.2.1 GSK Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.2.4 Drugs for Oral Mucositis Product Introduction
- 10.2.5 GSK Recent Development
- 10.3 Pfizer
- 10.3.1 Pfizer Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.3.4 Drugs for Oral Mucositis Product Introduction
- 10.3.5 Pfizer Recent Development
- 10.4 Colgate-Palmolive
- 10.4.1 Colgate-Palmolive Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.4.4 Drugs for Oral Mucositis Product Introduction
- 10.4.5 Colgate-Palmolive Recent Development
- 10.5 Norgine
- 10.5.1 Norgine Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.5.4 Drugs for Oral Mucositis Product Introduction
- 10.5.5 Norgine Recent Development
- 10.6 Biovitrum
- 10.6.1 Biovitrum Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.6.4 Drugs for Oral Mucositis Product Introduction
- 10.6.5 Biovitrum Recent Development
- 10.7 Valeant Pharmaceuticals
- 10.7.1 Valeant Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.7.4 Drugs for Oral Mucositis Product Introduction
- 10.7.5 Valeant Pharmaceuticals Recent Development
- 10.8 EUSA Pharma
- 10.8.1 EUSA Pharma Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.8.4 Drugs for Oral Mucositis Product Introduction
- 10.8.5 EUSA Pharma Recent Development
- 10.9 Camurus
- 10.9.1 Camurus Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.9.4 Drugs for Oral Mucositis Product Introduction
- 10.9.5 Camurus Recent Development
- 10.10 Mission Pharmacal
- 10.10.1 Mission Pharmacal Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Drugs for Oral Mucositis
- 10.10.4 Drugs for Oral Mucositis Product Introduction
- 10.10.5 Mission Pharmacal Recent Development
- 10.11 Clinigen Group
- 10.12 Midatech Pharma
- 10.13 Alliance Pharma
- 10.14 AMAG Pharmaceuticals
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Drugs for Oral Mucositis Sales Channels
- 11.2.2 Drugs for Oral Mucositis Distributors
- 11.3 Drugs for Oral Mucositis Customers
12 Market Forecast
- 12.1 Global Drugs for Oral Mucositis Sales and Revenue Forecast 2019-2025
- 12.2 Global Drugs for Oral Mucositis Sales Forecast by Type
- 12.3 Global Drugs for Oral Mucositis Sales Forecast by Application
- 12.4 Drugs for Oral Mucositis Forecast by Regions
- 12.4.1 Global Drugs for Oral Mucositis Sales Forecast by Regions 2019-2025
- 12.4.2 Global Drugs for Oral Mucositis Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Drugs for Oral Mucositis. Industry analysis & Market Report on Drugs for Oral Mucositis is a syndicated market report, published as Global (United States, European Union and China) Drugs for Oral Mucositis Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Drugs for Oral Mucositis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
